Inhibition of Dual/Mixed Tropic HIV-1 Isolates by CCR5-Inhibitors in Primary Lymphocytes and Macrophages
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Dual/Mixed Tropic HIV-1 Isolates by CCR5-Inhibitors in Primary Lymphocytes and Macrophages
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 7, Pages e68076
Publisher
Public Library of Science (PLoS)
Online
2013-07-10
DOI
10.1371/journal.pone.0068076
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies
- (2013) Lamorris M Loftin et al. Journal of Translational Medicine
- The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients
- (2012) M.M. Santoro et al. CLINICAL MICROBIOLOGY AND INFECTION
- Population-Based Sequencing of the V3-loop Can Predict the Virological Response to Maraviroc in Treatment-Naive Patients of the MERIT Trial
- (2012) Rachel A. McGovern et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Ultra-deep sequencing reveals hidden HIV-1 minority lineages and shifts of viral population between the main cellular reservoirs of the infection after therapy interruption
- (2012) Gabriella Rozera et al. JOURNAL OF MEDICAL VIROLOGY
- Macrophages and their relevance in Human Immunodeficiency Virus Type I infection
- (2012) Herwig Koppensteiner et al. Retrovirology
- Next-generation sequencing to assess HIV tropism
- (2012) Luke C. Swenson et al. Current Opinion in HIV and AIDS
- HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro
- (2011) Valentina Svicher et al. ANTIVIRAL RESEARCH
- Deep V3 Sequencing for HIV Type 1 Tropism in Treatment-Naive Patients: A Reanalysis of the MERIT Trial of Maraviroc
- (2011) Luke C. Swenson et al. CLINICAL INFECTIOUS DISEASES
- Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient
- (2011) J. Symons et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- European guidelines on the clinical management of HIV-1 tropism testing
- (2011) LPR Vandekerckhove et al. LANCET INFECTIOUS DISEASES
- Viral Determinants of HIV-1 Macrophage Tropism
- (2011) Christopher J. A. Duncan et al. Viruses-Basel
- HIV coreceptor tropism in antiretroviral treatment-naive patients newly diagnosed at a late stage of HIV infection
- (2010) Benedikt Simon et al. AIDS
- Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors
- (2010) Jonathan Toma et al. AIDS
- Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection
- (2010) David A. Cooper et al. JOURNAL OF INFECTIOUS DISEASES
- Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping
- (2010) Mattia CF Prosperi et al. Retrovirology
- Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients
- (2009) Aylin Yilmaz et al. AIDS
- Understanding the HIV coreceptor switch from a dynamical perspective
- (2009) Christel Kamp BMC EVOLUTIONARY BIOLOGY
- Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists
- (2009) E. Poveda et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” Antagonists
- (2009) Denis Sohy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Double‐Blind, Placebo‐Controlled Trial of Maraviroc in Treatment‐Experienced Patients Infected with Non‐R5 HIV‐1
- (2009) Michael Saag et al. JOURNAL OF INFECTIOUS DISEASES
- Co-receptor switch during HAART is independent of virological success
- (2009) Annalisa Saracino et al. JOURNAL OF MEDICAL VIROLOGY
- Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools
- (2009) Natalia Chueca et al. JOURNAL OF MEDICAL VIROLOGY
- Macrophages in Vaginal but Not Intestinal Mucosa Are Monocyte-Like and Permissive to Human Immunodeficiency Virus Type 1 Infection
- (2009) R. Shen et al. JOURNAL OF VIROLOGY
- Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
- (2009) Mayte Coiras et al. NATURE REVIEWS MICROBIOLOGY
- A pièce de resistance: how HIV-1 escapes small molecule CCR5 inhibitors
- (2009) John P Moore et al. Current Opinion in HIV and AIDS
- Suppression of Dualtropic Human Immunodeficiency Virus Type 1 by the CXCR4 Antagonist AMD3100 Is Associated with Efficiency of CXCR4 Use and Baseline Virus Composition
- (2008) S. Fransen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Impact of HIV Tropism on Decreases in CD4 Cell Count, Clinical Progression, and Subsequent Response to a First Antiretroviral Therapy Regimen
- (2008) Laura Waters et al. CLINICAL INFECTIOUS DISEASES
- HIV‐1 Tropism and Survival in Vertically Infected Ugandan Infants
- (2008) Jessica D. Church et al. JOURNAL OF INFECTIOUS DISEASES
- Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection
- (2008) Gerd Fätkenheuer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
- (2008) Roy M. Gulick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
- (2008) B. F. Keele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation